Brexit and the Impact on the Biotechnology Industry

11:00 AM - 12:00 PM, Wednesday, June 5,2019 ・ 115B, Level 100
How is the biotech sector likely to be impacted by Brexit, both in the UK and the EU? This panel discussion will address some key issues and questions that Brexit may raise, with a particular focus on cells and gene therapy development and commercialization. The panelists will consider all stages of these products' life cycle, to explore how each step may be affected by Brexit, from R&D through clinical trials, marketing authorization application and market supply as well as manufacturing and pharmacovigilance issues. Both perspectives of continental Europe and the UK will be discussed, taking into account the scenarios remaining on the table when the panel discussion will take place
Speakers
photo
Chairwoman
BIO.BE
photo
CEO
BioIndustry Association
photo
Healthcare Director
EuropaBio
photo
Scientific Officer
European Medicines Agency
photo
VP Business Development
MaSTherCell Global